← Scroll for more →
Arvinas, Inc. (ARVN)
Pharmaceutical Preparations
Latest Price
$7.90
TTM P/E
32.92
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
8.71
P/B Ratio
0.91
Institutional Ownership
83.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.61M | $63.0M | 11.65% | +811.5K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 4.12M | $34.0M | 6.31% | +233.8K | 2026-06-30 |
| D. E. Shaw & Co., Inc. | 3.50M | $29.0M | 5.35% | -143.4K | 2026-06-30 |
| Pfizer Inc | 3.46M | $27.0M | 5.30% | -- | 2026-06-30 |
| Armistice Capital, LLC | 2.80M | $23.0M | 4.28% | +818.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.71M | $22.0M | 4.16% | +24.8K | 2026-06-30 |
| Two Sigma Investments, LP | 2.57M | $21.0M | 3.94% | -- | 2026-06-30 |
| State Street Corp | 2.20M | $18.0M | 3.36% | +368.4K | 2026-06-30 |
| Geode Capital Management, LLC | 1.67M | $13.0M | 2.55% | +110.2K | 2026-06-30 |
| Qube Research & Technologies Ltd | 1.59M | $13.0M | 2.44% | +390.6K | 2026-06-30 |